Publication
Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial
Journal Paper/Review - Apr 25, 2021
Froesch Patrizia, Früh Martin, Gautschi Oliver, Sessa Cristiana, König David, Metaxas Yannis, Colombo Ilaria, Schmid Sabine, Oppliger Leibundgut Elisabeth, Rusterholz Corinne, Godar Gilles, Li Qiyu, Rothschild Sacha I, Mark Michael, Swiss Group for Clinical Cancer Research (SAKK)
Froesch, Patrizia
8
0
Mark, Michael
13
0
Rothschild, Sacha I
21
0
Li, Qiyu
9
0
Godar, Gilles
2
0
Rusterholz, Corinne
5
0
Oppliger Leibundgut, Elisabeth
1
0
Schmid, Sabine
33
8
Colombo, Ilaria
1
0
Metaxas, Yannis
5
0
König, David
2
0
Sessa, Cristiana
12
0
Gautschi, Oliver
88
4
Früh, Martin
Medizinische Onkologie und Hämatologie · Dept. I
124
37
Swiss Group for Clinical Cancer Research (SAKK),
31
0